What Happened
- Parliament passed the Jan Vishwas (Amendment of Provisions) Bill, 2026 — the Rajya Sabha cleared it after the Lok Sabha had passed it earlier in the Budget Session.
- The Bill amends 80 central Acts across 23 ministries to decriminalise or rationalise offences and penalties: 717 provisions have been decriminalised and 67 amended for ease of living.
- Imprisonment for minor, technical, and procedural violations is replaced with graded monetary penalties — a significant shift from a punitive to a facilitative regulatory model.
- The healthcare sector sees prominent changes: the Drugs and Cosmetics Act, 1940; the Pharmacy Act, 1948; the Food Safety and Standards Act; the Clinical Establishments (Registration and Regulation) Act, 2010; and the National Commission for Allied and Healthcare Professions Act, 2021 are all amended.
- Penalties will automatically increase by 10% of the minimum amount every three years, providing an inflation-indexed deterrence mechanism without requiring fresh legislation.
Static Topic Bridges
Decriminalisation and Ease of Doing Business — Policy Context
The decriminalisation of economic and regulatory offences has been a stated government priority since the 2020 economic reforms. The premise is that India's regulatory framework inherited colonial-era penal logic — treating minor procedural violations the same as serious crimes — which creates undue anxiety among businesses and healthcare professionals and deters investment. The first Jan Vishwas (Amendment of Provisions) Act was enacted in 2023, amending 183 provisions across 42 central laws. The 2026 Bill is the second, much larger iteration — covering more laws and a wider range of sectors. The OECD PMR (Product Market Regulation) indicator and the World Bank's now-discontinued Ease of Doing Business Index both tracked the removal of criminal liability for minor regulatory infractions as a key reform metric.
- Jan Vishwas Act, 2023: Amended 42 central Acts, decriminalised 183 provisions — the predecessor legislation
- Jan Vishwas Bill, 2026: Amends 80 Acts across 23 ministries; 717 provisions decriminalised; 67 further rationalised
- Ministry driving this: Ministry of Commerce and Industry (DPIIT) in coordination with sector ministries
- Tiered approach: First-time contraventions receive advisories or warnings before financial penalties apply
- Penalty auto-escalation: 10% increase in minimum penalty every 3 years — without legislative intervention
- Eliminates offences such as false fire alarms, failure to report births/deaths — redundant vestiges of colonial regulation
Connection to this news: The 2026 Bill extends the Jan Vishwas framework to twice as many laws as the 2023 Act, reflecting the government's view that the fear of criminal prosecution for paperwork errors significantly chills compliance culture in regulated sectors like healthcare.
Regulation of Drugs, Cosmetics and Medical Devices — Legal Framework
The Drugs and Cosmetics Act, 1940 is the primary legislation governing the manufacture, distribution, sale, and import of drugs, cosmetics, and medical devices in India. It divides drugs into schedules with varying regulatory stringency and provides for state licensing authorities and the Central Drugs Standard Control Organisation (CDSCO) for central oversight. The Act has historically carried prison terms for a wide range of infractions — including minor labelling errors for cosmetics and procedural non-compliance in distribution — even where there is no adulteration or risk to public health. The Jan Vishwas amendments specifically decouple cosmetic violations from the same punitive framework applied to spurious or adulterated drugs.
- Drugs and Cosmetics Act, 1940: Central Act; amended multiple times, most recently for medical devices (2017) and digital records
- CDSCO: Central licensing authority for drugs with national implications; state FDAs license manufacturing
- Pre-amendment: Minor cosmetic violations could attract imprisonment despite posing no public health risk
- Post-amendment: Cosmetic violations (other than spurious/adulterated) addressed via civil penalty framework only
- Pharmacy Act, 1948: Governs pharmacy practice and registration — penalties modernised and increased (monetary, not custodial)
- Serious violations (adulteration, spurious drugs harming patients) retain criminal penalty — the reform is explicitly targeted only at procedural/minor infractions
Connection to this news: By removing custodial liability for non-hazardous cosmetic violations and pharmacy procedural errors, the Bill reduces the compliance burden on healthcare workers and small pharmacists without compromising patient safety safeguards.
Clinical Establishments Act and Healthcare Governance
The Clinical Establishments (Registration and Regulation) Act, 2010 was enacted to establish a national framework for mandatory registration and regulation of clinical establishments (hospitals, clinics, diagnostic centres) across India. It applies to all clinical establishments except those of the central government, and allows states to adopt or adapt the framework. The Act sets minimum standards for facilities, personnel, and record-keeping. Prior to the Jan Vishwas amendments, deficiencies in paperwork or registration compliance could trigger criminal prosecution — a provision criticised by the Indian Medical Association as using criminal law to address what are essentially administrative lapses.
- Clinical Establishments Act, 2010: Applies to all states that have adopted it (many key states have not adopted it — an ongoing federal gap)
- National Council for Clinical Establishments: Standards-setting body under the Act
- Amendment effect: Monetary penalties replace criminal sanctions for registration and documentation deficiencies not posing immediate patient safety risks
- National Commission for Allied and Healthcare Professions Act, 2021: Also amended — governs allied health professionals (physiotherapists, optometrists, etc.); penalty provisions modernised
- Food Safety and Standards Act (FSSAI): Amendments similarly replace jail terms for minor food safety paperwork violations with civil penalties
Connection to this news: The amendment to the Clinical Establishments Act is significant for states where the law is fully operative, reducing the adversarial relationship between hospital administrators and regulators for paperwork compliance, while keeping criminal liability intact for patient safety violations.
Key Facts & Data
- Full name: Jan Vishwas (Amendment of Provisions) Bill, 2026
- Passed by: Both Houses of Parliament in Budget Session 2026
- Scope: Amends 80 central Acts administered by 23 ministries
- Total provisions amended: 784 (717 decriminalised + 67 rationalised)
- Predecessor: Jan Vishwas (Amendment of Provisions) Act, 2023 — 42 Acts, 183 provisions
- Key health laws amended: Drugs and Cosmetics Act (1940), Pharmacy Act (1948), Food Safety and Standards Act, Clinical Establishments Act (2010), Allied Healthcare Professions Act (2021)
- Cosmetic violations: Criminal liability removed for non-spurious, non-adulterated cosmetics
- Penalty escalation mechanism: Auto-increase of 10% of minimum penalty every 3 years
- Serious drug violations (adulteration, spurious drugs): Criminal penalties retained
- Government's stated objective: "Trust-based governance framework" — ease of living + ease of doing business
- PM's framing: Shift from "punishment" to "reform" in regulatory enforcement philosophy